EBOLA VACCINE MARKET ANALYSIS

Ebola Vaccine Market, By Virus Strain (Recombinant vesicular stomatitis virus-Zaire Ebola virus, Chimpanzee Adeno virus type 3-Zaire Ebola virus, and Adeno virus serotype 26- Zaire Ebola Virus) and by Geography — Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2022-2028

To Be Published : Oct 2024
Code : CMI1365
Formats :
Excel and PDF
Industry : Biotechnology

Leading Companies

GAVI is an international organization (global Vaccine Alliance) paid US$ 5 million to Merck & Company in 2016 for procurement of the vaccine (V 920 vaccine). Key players in the global Ebola vaccine market are Merck and Company, Janssen Pharmaceutica NV, GlaxoSmithKline, and Novavax Inc.